Psychedelic NewsApril 14, 2022 Gilgamesh Will Soon Complete Series B Funding As It Boosts Team, Pipeline, and Tech
Psychedelic NewsAugust 26, 2021 Mycelial Gallery Blends Crypto and Psychedelics to Raise Money For MAPS; Donates $108k
Psychedelic NewsJune 17, 2021 As a Public Company, Wesana Health Aims to Solve Traumatic Brain Injury
Psychedelic NewsJune 10, 2021 GH Research Files to Go Public Only Two Months After Raising $125 Million
Psychedelic NewsMay 28, 2021 Defiance ETFs Launches $PSY, the First U.S.-listed ETF Focused on Psychedelics
Psychedelic NewsMay 27, 2021 A Second Psychedelics ETF Prepares To Trade… Here are the Top 10 Holdings
Psychedelic NewsApril 28, 2021 MindMed Surpasses Compass Pathways As Largest Publicly Traded Psychedelic Company
Psychedelic NewsFebruary 19, 2021 Atai Life Sciences Partners with Bionomics on MDMA Combination Therapies
Psychedelic NewsDecember 17, 2020 A New Fund Dedicated to Psychedelic Investments Has Launched in the UK
Psychedelic NewsDecember 15, 2020 Christian Angermayer: ‘This Will be the Best Performing Asset Class Over the Next 20 Years’
